Adamas Pharma Shares Down 18.7% Following Earlier Announcement of Action Filed In Delaware Court By Osmotica and Vertical Pharmaceuticals Companies Regarding Its OSMOLEX ER Tablets; Co. Noted Complaint Does Not Allege Patent Infringement